ATARA BIOTHERAPEUTICS, INC. Finance Lease, Weighted Average Discount Rate, Percent
ATARA BIOTHERAPEUTICS, INC. (ATRA) had Finance Lease, Weighted Average Discount Rate, Percent of 0.00% as of 2025-12-31, per its 10-K filed 2026-03-16.
Financial Statements › Notes › Leases
us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent · last filed 2026-05-12
- 2025-12-31: Finance Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2025-09-30: Finance Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2025-06-30: Finance Lease, Weighted Average Discount Rate, Percent 0.00%.
- 2025-03-31: Finance Lease, Weighted Average Discount Rate, Percent 10.40%.
| Period end | Finance Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-16 |
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-12 |
| 2025-06-30 | 0.00% 10-Q · filed 2025-08-11 |
| 2025-03-31 | 10.40% 10-Q · filed 2026-05-12 |
| 2024-12-31 | 10.40% 10-K · filed 2026-03-16 |
| 2024-09-30 | 10.40% 10-Q · filed 2025-11-12 |
| 2024-06-30 | 10.40% 10-Q · filed 2025-08-11 |
| 2024-03-31 | 10.40% 10-Q · filed 2025-05-15 |
| 2023-12-31 | 10.40% 10-K · filed 2025-03-07 |
| 2022-12-31 | 10.40% 10-K · filed 2024-03-28 |
| 2022-09-30 | 10.40% 10-Q · filed 2022-11-08 |
| 2022-06-30 | 10.40% 10-Q · filed 2022-08-08 |
| 2021-12-31 | 9.70% 10-K · filed 2023-02-08 |
| 2021-09-30 | 9.60% 10-Q · filed 2022-11-08 |
| 2021-06-30 | 9.70% 10-Q · filed 2022-08-08 |
| 2020-12-31 | 9.70% 10-K · filed 2023-02-08 |
| 2019-12-31 | 10.00% 10-K · filed 2022-02-28 |
| 2019-09-30 | 9.90% 10-Q · filed 2019-11-07 |
| 2019-06-30 | 9.50% 10-Q · filed 2019-08-08 |
| 2019-03-31 | 9.50% 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |